Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31669
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTada, Hayato-
dc.contributor.authorYeo, Khung Keong-
dc.contributor.authorLi, Jian-Jun-
dc.contributor.authorTan, Kathryn-
dc.contributor.authorAko, Junya-
dc.contributor.authorKrittayaphong, Rungroj-
dc.contributor.authorSan Tan, Ru-
dc.contributor.authorAylward, Philip E-
dc.contributor.authorLam, Carolyn S P-
dc.contributor.authorBaek, Sang Hong-
dc.contributor.authorDalal, Jamshed-
dc.contributor.authorFong, Alan-
dc.contributor.authorLi, Yi-Heng-
dc.contributor.authorO'Brien, Richard C-
dc.contributor.authorNatalie Koh, Si Ya-
dc.contributor.authorScherer, Daniel J-
dc.contributor.authorKang, Vernon-
dc.contributor.authorNelson, Adam J-
dc.contributor.authorButters, Julie-
dc.contributor.authorNicholls, Stephen J-
dc.date2021-
dc.date.accessioned2023-01-12T01:59:58Z-
dc.date.available2023-01-12T01:59:58Z-
dc.date.issued2021-12-
dc.identifier.citationJACC. Asia 2021; 1(3):294-302en_US
dc.identifier.issn2772-3747-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31669-
dc.description.abstractApproximately one-half of the phenotypic susceptibility to atherosclerotic cardiovascular disease (ASCVD) has a genetic basis. Although individual allelic variants generally impart a small effect on risk for ASCVD, an emerging body of data has shown that the aggregation and weighting of many of these genetic variations into "scores" can further discriminate an individual's risk beyond traditional risk factors alone. Consistent with the theory of population genetics, such polygenic risk scores (PRS) appear to be ethnicity specific because their elements comprise single-nucleotide variants that are always ethnicity specific. The currently available PRS are derived predominantly from European ancestry and thus predictably perform less well among non-European participants, a fact that has implications for their use in the Asia-Pacific region. This paper describes the current state of knowledge of PRS, the available data that support their use in this region, and highlights the needs moving forward to safely and effectively implement them in clinical care in the Asia-Pacific region.en_US
dc.language.isoeng-
dc.subjectASCVD, atherosclerotic cardiovascular diseaseen_US
dc.subjectAsia-Pacificen_US
dc.subjectFH, familial hypercholesterolemiaen_US
dc.subjectGWAS, genome-wide association studiesen_US
dc.subjectLDL, low-density lipoproteinen_US
dc.subjectPRS, polygenic risk score(s)en_US
dc.subjectSNV, single-nucleotide varianten_US
dc.subjectcardiovascular diseaseen_US
dc.subjectgeneticsen_US
dc.subjectpolygenic risk scoreen_US
dc.titlePolygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleJACC. Asiaen_US
dc.identifier.affiliationDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.en_US
dc.identifier.affiliationNational Heart Centre and SingHealth Duke-NUS Cardiovascular Sciences, Singapore.en_US
dc.identifier.affiliationState Key Laboratory of Cardiovascular Disease, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.en_US
dc.identifier.affiliationDepartment of Medicine, University of Hong Kong, Hong Kong.en_US
dc.identifier.affiliationKitasato University, Sagamihara, Japan.en_US
dc.identifier.affiliationDivision of Cardiology, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.en_US
dc.identifier.affiliationNational Heart Centre and SingHealth Duke-NUS Cardiovascular Sciences, Singapore.en_US
dc.identifier.affiliationSouth Australian Health and Medical Research Institute and Flinders University, Adelaide, South Australia, Australia.en_US
dc.identifier.affiliationNational Heart Centre and SingHealth Duke-NUS Cardiovascular Sciences, Singapore.en_US
dc.identifier.affiliationSeoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.en_US
dc.identifier.affiliationKokilaben Hospital, Mumbai, India.en_US
dc.identifier.affiliationDepartment of Cardiology, Sarawak Heart Centre, and Clinical Research Centre, Sarawak General Hospital, Kuching, Malaysia.en_US
dc.identifier.affiliationNational Cheng Kung University Hospital, Tainan, Taiwan.en_US
dc.identifier.affiliationUniversity of Melbourne Clinical Schoolen_US
dc.identifier.affiliationNational Heart Centre and SingHealth Duke-NUS Cardiovascular Sciences, Singapore.en_US
dc.identifier.affiliationSouth Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.en_US
dc.identifier.affiliationSingapore Heart Foundation, Singapore.en_US
dc.identifier.affiliationVictorian Heart Institute, Monash University, Melbourne, Victoria, Australia.en_US
dc.identifier.doi10.1016/j.jacasi.2021.08.008en_US
dc.type.contentTexten_US
dc.identifier.pubmedid36341217-
dc.description.volume1-
dc.description.issue3-
dc.description.startpage294-
dc.description.endpage302-
local.name.researcherO'Brien, Richard C
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
crisitem.author.deptEndocrinology-
crisitem.author.deptUniversity of Melbourne Clinical School-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

40
checked on Dec 20, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.